Table 2.

PAH-specific medications of Korean Registry of Pulmonary Arterial Hypertension in all patients and incident patients

Medication	Treatments in all patients (n = 626)	Treatments in incidence cases (n = 297)
No. (%) of patients receiving PAH-specific medications in all treatments	380 (60.8)	182 (61.3)
No. (%) of medications in all PAH-specific treatments
Single bosentan	155 (40.9)	93 (51.1)
Single sildenafil	45 (11.8)	21 (11.6)
Single inhaled ilprost	22 (5.8)	17 (9.3)
Single beraprost	86 (22.6)	23 (12.6)
Combinations of above single medications	72 (18.9)	28 (15.4)

Values are presented as number (%). Reprinted from Chung et al. [9].

PAH, pulmonary arterial hypertension.